FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979916062> ?p ?o ?g. }

• W1979916062 endingPage "699" @default.
• W1979916062 startingPage "691" @default.
• W1979916062 abstract "Summary Sirolimus has been shown to have activity against human acute lymphoblastic leukaemia at serum levels used for immunosuppression. We hypothesized that the addition of sirolimus to a tacrolimus/methotrexate graft‐ versus ‐host disease (GVHD) prophylaxis regimen would decrease relapse after haematopoietic stem cell transplantation and initiated a phase I/II study to demonstrate safety, feasibility, and efficacy. The study cohort included 18 patients in high‐risk (HR) first complete remission (CR1), 16 in HR CR2, 17 in intermediate risk (IR) CR2, and 12 in CR3+. The 2‐year event‐free survival (EFS) of the cohort was 66% (standard error 6·4). EFS of risk groups was 74%, 81%, 44% and 46% for CR1, IR CR2, HR CR2 and CR3+ patients respectively, and did not differ by stem cell source. Cumulative incidence of acute GVHD grade II–IV and III–IV was 38% and 21% respectively, while the cumulative incidence of chronic GVHD was 32%. Cumulative incidence of transplant‐related mortality and relapse was 10% and 25% respectively. Significant toxicities included veno‐occlusive disease [seven patients (11%)], transplant‐associated microangiopathy (three patients), and idiopathic pneumonitis (one patient). In summary, sirolimus‐based GVHD prophylaxis can be given safely in this population and early survival results are promising. A phase III trial to test whether sirolimus decreases relapse and improves outcome after transplantation for ALL is ongoing." @default.
• W1979916062 created "2016-06-24" @default.
• W1979916062 creator A5000313502 @default.
• W1979916062 creator A5003706795 @default.
• W1979916062 creator A5006173110 @default.
• W1979916062 creator A5026070694 @default.
• W1979916062 creator A5031592776 @default.
• W1979916062 creator A5041009445 @default.
• W1979916062 creator A5057064072 @default.
• W1979916062 creator A5077440294 @default.
• W1979916062 date "2009-11-06" @default.
• W1979916062 modified "2023-10-18" @default.
• W1979916062 title "A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft<i>versus</i>host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)" @default.
• W1979916062 cites W1969094894 @default.
• W1979916062 cites W1970134522 @default.
• W1979916062 cites W1971682146 @default.
• W1979916062 cites W1972172571 @default.
• W1979916062 cites W1973617793 @default.
• W1979916062 cites W1975293227 @default.
• W1979916062 cites W1975946124 @default.
• W1979916062 cites W1981937443 @default.
• W1979916062 cites W1987959125 @default.
• W1979916062 cites W1989270320 @default.
• W1979916062 cites W1993017155 @default.
• W1979916062 cites W2003182588 @default.
• W1979916062 cites W2007208181 @default.
• W1979916062 cites W2018910109 @default.
• W1979916062 cites W2024327060 @default.
• W1979916062 cites W2026351725 @default.
• W1979916062 cites W2028104399 @default.
• W1979916062 cites W2030690009 @default.
• W1979916062 cites W2032542882 @default.
• W1979916062 cites W2040886821 @default.
• W1979916062 cites W2043216329 @default.
• W1979916062 cites W2053278212 @default.
• W1979916062 cites W2072301202 @default.
• W1979916062 cites W2075139424 @default.
• W1979916062 cites W2080986723 @default.
• W1979916062 cites W2085290177 @default.
• W1979916062 cites W2086891287 @default.
• W1979916062 cites W2092925278 @default.
• W1979916062 cites W2119770188 @default.
• W1979916062 cites W2134654916 @default.
• W1979916062 cites W2155616447 @default.
• W1979916062 cites W2157460080 @default.
• W1979916062 cites W2157732996 @default.
• W1979916062 cites W4214512856 @default.
• W1979916062 cites W4242108431 @default.
• W1979916062 cites W4244454557 @default.
• W1979916062 cites W4293241248 @default.
• W1979916062 cites W59733412 @default.
• W1979916062 doi "https://doi.org/10.1111/j.1365-2141.2009.07889.x" @default.
• W1979916062 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2888481" @default.
• W1979916062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19744131" @default.
• W1979916062 hasPublicationYear "2009" @default.
• W1979916062 type Work @default.
• W1979916062 sameAs 1979916062 @default.
• W1979916062 citedByCount "25" @default.
• W1979916062 countsByYear W19799160622012 @default.
• W1979916062 countsByYear W19799160622013 @default.
• W1979916062 countsByYear W19799160622014 @default.
• W1979916062 countsByYear W19799160622015 @default.
• W1979916062 countsByYear W19799160622016 @default.
• W1979916062 countsByYear W19799160622020 @default.
• W1979916062 crossrefType "journal-article" @default.
• W1979916062 hasAuthorship W1979916062A5000313502 @default.
• W1979916062 hasAuthorship W1979916062A5003706795 @default.
• W1979916062 hasAuthorship W1979916062A5006173110 @default.
• W1979916062 hasAuthorship W1979916062A5026070694 @default.
• W1979916062 hasAuthorship W1979916062A5031592776 @default.
• W1979916062 hasAuthorship W1979916062A5041009445 @default.
• W1979916062 hasAuthorship W1979916062A5057064072 @default.
• W1979916062 hasAuthorship W1979916062A5077440294 @default.
• W1979916062 hasBestOaLocation W19799160622 @default.
• W1979916062 hasConcept C126322002 @default.
• W1979916062 hasConcept C141071460 @default.
• W1979916062 hasConcept C207103383 @default.
• W1979916062 hasConcept C2776694085 @default.
• W1979916062 hasConcept C2776755627 @default.
• W1979916062 hasConcept C2777408962 @default.
• W1979916062 hasConcept C2777921159 @default.
• W1979916062 hasConcept C2778880498 @default.
• W1979916062 hasConcept C2779972918 @default.
• W1979916062 hasConcept C2780252810 @default.
• W1979916062 hasConcept C2781059491 @default.
• W1979916062 hasConcept C2908647359 @default.
• W1979916062 hasConcept C2909675724 @default.
• W1979916062 hasConcept C2911091166 @default.
• W1979916062 hasConcept C44249647 @default.
• W1979916062 hasConcept C71924100 @default.
• W1979916062 hasConcept C72563966 @default.
• W1979916062 hasConcept C88879693 @default.
• W1979916062 hasConcept C90924648 @default.
• W1979916062 hasConcept C99454951 @default.
• W1979916062 hasConceptScore W1979916062C126322002 @default.
• W1979916062 hasConceptScore W1979916062C141071460 @default.
• W1979916062 hasConceptScore W1979916062C207103383 @default.
• W1979916062 hasConceptScore W1979916062C2776694085 @default.

• next